Drug Trial Radar · NCT03342053
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)
Last checked: Nov 19, 2026Latest source record: Mar 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Jan 2, 2018
Primary completion
Oct 8, 2019
Study completion Oct 8, 2019
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Nov 14, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7234292 administered intrathecally to adult patients with Huntington's Disease.
Conditions
- Huntington's Disease
Interventions
RO7234292 (RG6042)Drug
Intrathecal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Adverse EventsTime frame: From baseline up to 18 months
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
The University of British Columbia; The Centre for Huntington Disease
Vancouver, British Columbia, Canada
Charité - Universitätsmedizin Berlin, Campus Charité Mitte; Klinik für Psychiatrie und Psychotherapi
Berlin, Germany
St. Josef and St. Elisabeth GmbH ; Klinikum Bochum, Zentralapotheke
Bochum, Germany
Universitaetsklinikum Ulm
Ulm, Germany
NIHR Welcome Trust Birmingham CRF - University Hospitals Birmingham; Department of Neuropsychiatry
Birmingham, United Kingdom
University of Cambridge - John van Geest Centre for Brain Repair
Cambridge, United Kingdom
Cardiff University School of Medicine; Institute of Psychological Medicine Clinical Neurosciences
Cardiff, United Kingdom
Leonard Wolfson Experimental Neurology Centre
London, United Kingdom
Central Manchester University Hospitals NHS Foundation Trust; Manchester Centre for Genomic Medicine
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.